Quick Facts

Share SHARE

A special Chinese investigation team questioned Microsoft's (MSFT) Vice President David Chen and other staff members on the company's alleged monopoly activities in China, and asked the company to give a written explanation within 20 days. The state-run Xinhua news agency reported that the team led...

Scientific Games Corp. (SGMS) Monday said it has named Dan Savage as its Vice President, Corporate Marketing. The company said Savage will work closely with the its Gaming, Lottery and Interactive groups to identify, evaluate and leverage opportunities to increase player appeal and positioning in...

Insurance giant American International Group Inc. (AIG) said that Peter Hancock has assumed the role of President and Chief Executive Officer of the company, and has joined AIG's Board of Directors. Hancock succeeds Robert Benmosche, who retired and now serves as an advisor to AIG. Hancock, 56, joined...

Apple Inc. (AAPL) plans to turn its next iPhone into a mobile wallet through a partnership with major payment networks, banks and retailers, Bloomberg reported citing a person familiar with the matter. The agreement includes Visa Inc. (V), MasterCard Inc. (MA) and American Express Co. (AXP) and will...

Ablynx (ABLYF.PK) said Monday that it has expanded its relationship with Eddingpharm, China-based specialty pharmaceutical company, by granting Eddingpharm an exclusive, royalty-bearing license to develop and commercialise Ablynx's anti-TNFa Nanobody, ozoralizumab (ATN-103), in the mainland of the People's...

French pharmaceutical firm Ipsen (IPSEY) said Monday that the U.S. Food and Drug Administration or FDA has accepted and granted priority review of its supplemental New Drug Application or sNDA for Somatuline Depot 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors or GEP-NETs. The...

UCB announced that the U.S. Food and Drug Administration has approved a supplemental new drug application (sNDA) for VIMPAT (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older. This is a new indication for VIMPAT which is already...

GE Healthcare, a unit of General Electric Co. (GE), announced that Vizamyl (flutemetamol (18F) solution for injection) has received marketing authorisation from the European Commission as a radiopharmaceutical medicinal product indicated for Positron Emission Tomography or PET imaging of beta amyloid...

Crown Holdings Inc. (CCK) said Monday that it agreed to acquire Empaque, a leading Mexican manufacturer of aluminum cans and ends, bottle caps and glass bottles for the beverage industry, from Dutch brewer Heineken N.V. (HINKY.PK), in a cash transaction valued at $1.225 billion, subject to adjustment. The...

ResMed (RMD) announced results from a study presented at the ESC Congress 2014 in Barcelona, Spain, looking at the use of the at-home, contactless, bedside SleepMinder device to diagnose sleep-disordered breathing or SDB, the most common co-morbidity in patients with heart failure or HF. The company...

Sanofi (SNY) and Regeneron Pharmaceuticals Inc. (REGN) announced detailed positive results from four Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia. Results from the four ongoing trials, all of which met their primary efficacy endpoint, will be presented today at a Hot Line...

Lockheed Martin (LMT), Saturday announced its partnership with Warsaw University has demonstrated the first phase of flight test and integration of unmanned aircraft platforms with an autonomous mission control system. Professor Janusz Narkiewicz, the leader and scientific manager of the project from...

Novartis (NVS), revealed its investigational heart failure medicine, LCZ696, which was considered to be superior to ACE-inhibitor enalapril on key endpoints in a heart failure study. LCZ696 is an Angiotensin Receptor Neprilysin Inhibitor and has a unique mode of action which is thought to reduce the...

Medical device company ArthroCare Corp.'s (ARTC, ARTC.PK) ex- chief executive officer Michael Baker and the company's former finance chief Michael Gluk were sentenced to imprisonment on Friday, after they were found guilty of plotting a $750 million securities fraud scheme. The court sentenced Baker...

Global alternative asset manager Carlyle Group L.P. (CG) has agreed to pay $115 million to settle a collusion case, which accused the company for conspiring with other private-equity firms to not to bid against one another in eight corporate takeovers that happened during the mid-2000s, according to...